- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02806427
Tolerance of a Calorically Dense Enteral Nutrition Formula
June 29, 2017 updated by: Nestlé
This prospective observational study seeks to demonstrate the ability to meet nutritional needs of a calorically dense enteral formula in critically ill patients.
Study Overview
Study Type
Observational
Enrollment (Actual)
29
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States, 73104
- OUHSC
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Adults with established enteral access receiving standard tube feeding formula in the ICU
Description
Inclusion Criteria:
- Adult aged > 18 years
- Admitted to Medical ICU with expected admission of ≥ 3 days
- Established enteral access
- Having obtained his/her or legal representative's informed consent.
Exclusion Criteria:
- Pregnant or lactating
- Condition which contraindicates enteral feeding (i.e. intestinal obstruction)
- Lack of enteral access
- Parenteral nutrition
- Any condition that would contraindicate use of the study product (i.e. need for severe fluid restriction, cow's milk protein allergy, etc.)
- Subject who in the Investigator's assessment cannot be expected to comply with study protocol
- Currently participating in another conflicting clinical trial.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
enterally fed adults
Adults subjects with a condition for which a calorically dense enteral formula is appropriate, with established enteral access, anticipated to require enteral tube feeding for at least 3 days.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Daily percentage of caloric nutritional goal met
Time Frame: First 3 days in the ICU
|
First 3 days in the ICU
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Daily percentage of protein goal met
Time Frame: First 5 days in the ICU
|
First 5 days in the ICU
|
|
Adverse events and serious adverse events
Time Frame: First 5 days in the ICU
|
First 5 days in the ICU
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Karen Allen, MD, Oklahoma University Health Sciences Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 30, 2016
Primary Completion (Actual)
March 11, 2017
Study Completion (Actual)
March 11, 2017
Study Registration Dates
First Submitted
June 16, 2016
First Submitted That Met QC Criteria
June 16, 2016
First Posted (Estimate)
June 20, 2016
Study Record Updates
Last Update Posted (Actual)
July 2, 2017
Last Update Submitted That Met QC Criteria
June 29, 2017
Last Verified
June 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- 15.08.US.HCN
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Enteral Feeding
-
Children's Mercy Hospital Kansas CityNot yet recruitingEnteral Nutrition | Tube Feeding | Clogged Enteral Access Devices | Occluded Enteral Access Devices | Enteral Access Device | Gastric Feeding Tubes
-
University of MichiganChildren's Mercy Hospital Kansas CityTerminatedEnteral Nutrition | Enteral Feeding | Gastrostomy TubeUnited States
-
Société des Produits Nestlé (SPN)CompletedEnteral FeedingUnited States
-
Société des Produits Nestlé (SPN)Nutrasource Pharmaceutical and Nutraceutical Services, Inc.; Bruyere Research...Terminated
-
Société des Produits Nestlé (SPN)Completed
-
NestléCompleted
-
University of Illinois at ChicagoNot yet recruitingEnteral Nutrition FeedingUnited States
-
Centre Hospitalier Saint Joseph Saint Luc de LyonRecruitingEnteral Feeding IntoleranceFrance
-
Sohag UniversityRecruitingEnteral Feeding IntoleranceEgypt
-
Brno University HospitalRecruitingEnteral Feeding IntoleranceCzechia
Clinical Trials on Enteral Formula
-
Brno University HospitalRecruitingEnteral Feeding IntoleranceCzechia
-
Hospital Moinhos de VentoCompleted
-
Tungs' Taichung Metroharbour HospitalCompletedCritical Illness | Enteral NutritionTaiwan
-
NestléCompletedEnteral Feeding Intolerance | Children Requiring Amino Acid-based Formula Tube FeedingUnited States
-
NestléCompletedEnteral Feeding IntoleranceCanada
-
NestléCompleted
-
Société des Produits Nestlé (SPN)Completed
-
NestléCompletedCritically Ill ChildrenUnited States